(2006). Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. http://doi.org/10.1002/art.22117
. C. Cooper
First name
C.
Last name
Cooper
(2007). Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int. http://doi.org/10.1007/s00223-006-0213-1
. (2007). The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis. Arthritis Rheum. http://doi.org/10.1002/art.23003
. (2007). Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. http://doi.org/10.1002/art.22294
. (2007). Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kel249
. (2007). Lithium use and the risk of fractures. Bone. http://doi.org/10.1016/j.bone.2006.12.055
. (2008). Individualizing the risks and benefits of postmenopausal hormone therapy. Menopause. http://doi.org/10.1097/gme.0b013e31812e558f
. (2008). How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?. Arthritis Rheum. http://doi.org/10.1002/art.24015
. (2009). Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. http://doi.org/10.1007/s00198-009-0891-4
. (2010). Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database. Osteoporos Int. http://doi.org/10.1007/s00198-009-1050-7
.